Myeloproliferative Neoplasms (MPN)

New Poll: Americans Believe It’s Time to Protect Consumers From Predatory Short-Term Health Plans

Burlington Stores’ 20th Consecutive In-Store Fundraising Campaign Raises Nearly $3.4 Million for The Leukemia & Lymphoma Society

LLS Statement on COVID-19 Omicron Variant for Blood Cancer Patients and Survivors

FDA Approves First Drug for The Prevention of Acute Graft Versus Host Disease

LLS Applauds House Passage of Critical Health Reforms

FDA Approves the First Interferon for Adults With Polycythemia Vera

Olympic Athletes Join The Leukemia & Lymphoma Society's "Shred For Red" Event to Fight Blood Cancer

Leveraging dysregulated signaling networks for therapeutic benefit in myeloproliferative neoplasms

Submitted by daviss on October 22, 2021

Unfolding selective pathway dependencies of CALR mutated myeloproliferative neoplasms

Submitted by diamondr on October 22, 2021

Cytokine induced memory-like NK cell immunotherapy to target post transplant relapse

Submitted by daviss on October 22, 2021
Subscribe to Myeloproliferative Neoplasms (MPN)

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.